CY1111328T1 - Χαρακτηρισμος: αξομαδολη για τη θεραπεια πονου σε αρθριτιδα - Google Patents

Χαρακτηρισμος: αξομαδολη για τη θεραπεια πονου σε αρθριτιδα

Info

Publication number
CY1111328T1
CY1111328T1 CY20111100191T CY111100191T CY1111328T1 CY 1111328 T1 CY1111328 T1 CY 1111328T1 CY 20111100191 T CY20111100191 T CY 20111100191T CY 111100191 T CY111100191 T CY 111100191T CY 1111328 T1 CY1111328 T1 CY 1111328T1
Authority
CY
Cyprus
Prior art keywords
axomadoli
pain treatment
arthritis pain
treatment
arthritis
Prior art date
Application number
CY20111100191T
Other languages
English (en)
Inventor
Klaus Schiene
Petra Bloms-Funke
John Bothmer
Claudia Lefeber
Original Assignee
Grünenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH
Publication of CY1111328T1 publication Critical patent/CY1111328T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Η εφεύρεση αφορά τη χρησιμοποίηση αξομαδόλης για την παρασκευή ενός φαρμάκου για τη θεραπεία πόνου σε αρθρίτιδα.
CY20111100191T 2007-05-11 2011-02-16 Χαρακτηρισμος: αξομαδολη για τη θεραπεια πονου σε αρθριτιδα CY1111328T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007022790A DE102007022790A1 (de) 2007-05-11 2007-05-11 Axomadol zur Schmerzbehandlung bei Arthrose
EP08758440A EP2155179B1 (de) 2007-05-11 2008-05-09 Axomadol zur schmerzbehandlung bei arthrose

Publications (1)

Publication Number Publication Date
CY1111328T1 true CY1111328T1 (el) 2015-08-05

Family

ID=39672675

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100191T CY1111328T1 (el) 2007-05-11 2011-02-16 Χαρακτηρισμος: αξομαδολη για τη θεραπεια πονου σε αρθριτιδα

Country Status (22)

Country Link
US (2) US20080306161A1 (el)
EP (1) EP2155179B1 (el)
JP (1) JP2010526786A (el)
KR (1) KR20100017781A (el)
CN (1) CN101742993A (el)
AT (1) ATE489947T1 (el)
AU (1) AU2008250621A1 (el)
CA (1) CA2685379A1 (el)
CY (1) CY1111328T1 (el)
DE (2) DE102007022790A1 (el)
DK (1) DK2155179T3 (el)
ES (1) ES2357355T3 (el)
HK (1) HK1141436A1 (el)
HR (1) HRP20110127T1 (el)
IL (1) IL202001A0 (el)
MX (1) MX2009012096A (el)
PL (1) PL2155179T3 (el)
PT (1) PT2155179E (el)
RU (1) RU2009145804A (el)
SI (1) SI2155179T1 (el)
WO (1) WO2008138558A1 (el)
ZA (1) ZA200907646B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110060053A1 (en) 2002-09-09 2011-03-10 Gruenenthal Gmbh Crystalline Modifications of 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol
WO2011008298A2 (en) * 2009-07-16 2011-01-20 Nectid, Inc. Novel axomadol dosage forms
AR077987A1 (es) 2009-08-28 2011-10-05 Gruenenthal Gmbh Combinacion farmaceutica que comprende 6-dimetilaminometil-1-(3-metoxifenil)-ciclohexano-1,3-diol o 6-dimetilaminometil-1-(3-hidroxifenil)-ciclohexano-1,3-diol y un antiepileptico
WO2012000667A1 (en) * 2010-06-30 2012-01-05 Grünenthal GmbH Axomadol or metabolite thereof for use in the treatment of irritable bowel syndrome

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE10004926A1 (de) * 2000-02-04 2001-08-09 Gruenenthal Gmbh Verfahren zur enzymatischen Racematspaltung von Aminomethyl-Aryl-Cyclohexanol-Derivaten
DE10059413A1 (de) * 2000-11-30 2002-06-20 Gruenenthal Gmbh Verwendung von substituierten 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz
DE10109763A1 (de) 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
US20050176790A1 (en) * 2001-02-28 2005-08-11 Johannes Bartholomaus Pharmaceutical salts
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
EP1908460A1 (de) * 2002-11-22 2008-04-09 Grünenthal GmbH Verwendung von (1R,2R)-3-(2-Dimethylaminomethyl-cyclohexyl)-phenol zur Behandlung von Entzündungsschmerz
DE10333835A1 (de) 2003-07-24 2005-03-10 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol enthaltendes Arzneimittel mit verzögerter Wirkstofffreisetzung
PL1765303T5 (pl) * 2004-07-01 2023-05-22 Grünenthal GmbH Tabletka doustna zabezpieczona przed nadużywaniem
JP2008531511A (ja) * 2005-02-25 2008-08-14 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング （１ｒｓ，３ｒｓ，６ｒｓ）−６−ジメチルアミノメチル−１−（３−メトキシ−フェニル）シクロヘキサン−１，３−ジオール塩酸塩の結晶形
DE102005009217A1 (de) * 2005-02-25 2006-08-31 Grünenthal GmbH Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen

Also Published As

Publication number Publication date
CN101742993A (zh) 2010-06-16
DE102007022790A1 (de) 2008-11-20
SI2155179T1 (sl) 2011-03-31
ZA200907646B (en) 2010-07-28
PL2155179T3 (pl) 2011-05-31
DK2155179T3 (da) 2011-03-07
IL202001A0 (en) 2010-06-16
US20100331424A1 (en) 2010-12-30
EP2155179A1 (de) 2010-02-24
DE502008001951D1 (de) 2011-01-13
HK1141436A1 (en) 2010-11-12
ATE489947T1 (de) 2010-12-15
AU2008250621A1 (en) 2008-11-20
ES2357355T3 (es) 2011-04-25
EP2155179B1 (de) 2010-12-01
RU2009145804A (ru) 2011-06-20
CA2685379A1 (en) 2008-11-20
US20080306161A1 (en) 2008-12-11
MX2009012096A (es) 2009-11-23
HRP20110127T1 (hr) 2011-03-31
PT2155179E (pt) 2011-03-07
JP2010526786A (ja) 2010-08-05
KR20100017781A (ko) 2010-02-16
WO2008138558A1 (de) 2008-11-20

Similar Documents

Publication Publication Date Title
CY1122522T1 (el) Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος
CY1124144T1 (el) Συνθεσεις και μεθοδοι για θεραπεια εγκεφαλικου επεισοδιου σε ενα υποκειμενο επι ταυτοχρονης θεραπειας στατινης
CY1121327T1 (el) Τροποποιημενα αντισωματα anti-il-23p19
NL301145I2 (nl) Tirbanibulin
CY1118349T1 (el) Παραγοντες συνδεσης me cd19 και χρησεις αυτων
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
EA201001372A1 (ru) Формы рифаксимина и их применение
EA201171367A1 (ru) Винилиндазолильные соединения
EA200970737A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
RS53893B1 (en) USE OF BIOTIN FOR MULTIPLE SCLEROSIS TREATMENT
CY1115975T1 (el) Ταπενταδολη για τη θεραπεια πονου σε αρθριτιδα
CL2012003385A1 (es) Tratamiento para la incontinencia.
EA201170832A1 (ru) Пуриновые соединения
CR20110658A (es) Antagonistas de la trayectoria hedgehog de ftalazina desustituida
RS53466B (en) USE OF AMISULPRID FOR THE TREATMENT OF POSTOPERATIVE Nausea and Vomiting
MA32349B1 (fr) Antagonistes de la voie hedgehog a base de phtalazines disubstituees
BRPI0814772A2 (pt) Indazóis substituídos por 5-piridinona
BRPI0820440A2 (pt) Inibidores aldh-2 no tratamento de desordens psiquiátricas
DK2173831T3 (da) Brøndbehandling
UA112760C2 (uk) Теобромін у комбінації з гвайфенезином для лікування кашлю
CY1111328T1 (el) Χαρακτηρισμος: αξομαδολη για τη θεραπεια πονου σε αρθριτιδα
CY1117251T1 (el) Μεθοδοι θεραπευτικης αντιμετωπισης της σκληροδερμιας
EA200970816A1 (ru) Новая лекарственная форма
EA200971067A1 (ru) Триазолиламинопиримидиновые соединения
EA201390757A1 (ru) БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПРОИЗВОДСТВА